Google Alert - Ebola

	Ebola As-it-happens update ⋅ July 29, 2020
	NEWS
	Ridgeback Biotherapeutics LP Announces Priority Review of Biologics License Application for ... Business Wire The FDA granted Breakthrough Therapy Designation status to ansuvimab as a treatment for Ebola in September 2019. Wendy Holman, CEO and ... Flag as irrelevant
	WEB
	The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 Semantic Scholar ABSTRACT The Ebola virus VP35 protein was previously found to act as an interferon (IFN) antagonist which could complement growth of influenza ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback